• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Biosimilars Poll: What are the characteristics of a healthy biologics marketplace?

Article

Opposing interests make it hard to define what elements are essential for a competitive marketplace.

Take the Biosimilars Poll!

Person voting with a ballot box

As a recent report from Amgen made clear, biosimilars are gaining ground in the biologics marketplace, but across drug categories the pace of this advance is highly uneven.

Which of these is most characteristic of a healthy biologics marketplace?

Innovator companies develop new products that capture share from biosimilars.
Reference product prices decline to match biosimilar discounts.
Regulators establish policies to favor biosimilar use.

Check out the results from our last poll:

Infographic with a pie chart of the responses from our last poll

Click to enlarge

Related Content
question mark | Image credit: Duminda - stock.adobe.com

Quiz: Biosimilar Market Dynamics and Trends

April 2nd 2024
Article

Have you been keeping up with the latest market trends? Take this quiz to find out how well you know the global biosimilars market.

question mark | Image credit: Duminda - stock.adobe.com

Quiz: The Global Biosimilar Landscape

March 1st 2024
Article

Explore the dynamic world of global biosimilar markets and policies! What do you know about the international biosimilar industry?

question mark | Image credit: Duminda - stock.adobe.com

Quiz: How Well Do You Know These Biosimilar Policy Essentials?

February 9th 2024
Article

Test your knowledge of major biosimilar policies, including challenging regulatory frameworks from around the world.

question mark | Image credit: Duminda - stock.adobe.com

Quiz: The Basics of Biosimilars

January 8th 2024
Article

Intro to Biosimilars is now in session! Test yourself on how well you know these biosimilar basics.

In Canada, the Northwest Territories Switch to Biosimilars

In Canada, More Mandatory Switching

December 23rd 2021
Article

In Canada, a new jurisdiction inaugurates mandatory switching to biosimilars.

Alvotech Gains EC Approval for Adalimumab Biosimilar

Alvotech Gains EC Approval for Adalimumab Biosimilar

December 16th 2021
Article

Alvotech has received European Commission (EC) approval to begin marketing its adalimumab biosimliar AVT02, the company announced this week.

© 2024 MJH Life Sciences

All rights reserved.